Clinical trial Recruiting at 7 sites Observational Ages 18 and up

Italian registry for Head and Neck cancer patients

Official title: AIOCC Italian Registry on Head and Neck Carcinomas

Run by Italian Head&Neck Society · NCT06248944 · Data updated 2026-11-12

This study is setting up a registry in Italy to collect important information about people with head and neck cancer to help improve research and treatment options.

More Head and Neck Carcinoma trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment7000 (estimated)
SponsorItalian Head&Neck Society
Academic / other
Locations7 sites (Candiolo and 6 other locations)
StatusRecruiting
StartedJuly 6, 2022
Main results expectedJuly 6, 2027
Study endsJuly 6, 2027
Registry record updatedMarch 8, 2024
Trial IDNCT06248944 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adult patients aged 18 and older diagnosed with Head and Neck carcinoma, regardless of their current treatment phase.

Probably not a fit

Patients with sarcomas or lymphomas, or those whose medical records are unavailable for review, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish a clinical registry in Italy to collect comprehensive data on patients diagnosed with Head and Neck carcinoma. It will gather information from multiple healthcare providers across selected investigational sites, allowing for both retrospective and prospective data collection. The data will be entered into an electronic case report form (eCRF) by healthcare professionals and analyzed using a privacy-preserving federated learning system called Vantage6. The registry will support observational studies and facilitate global collaborative research efforts.

Why it matters

Potential benefit: If successful, this registry could enhance understanding of Head and Neck cancer treatment outcomes and improve patient care.

How similar studies have gone: Other observational registries have shown success in improving patient outcomes and facilitating research in similar cancer types.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adult patients (age ≥ 18 years old) diagnosed with carcinoma of the Head and Neck. The diagnosis should be done or verified by the expert site entering the information about the patient in the registry. Patients diagnosed with sarcomas and lymphomas are excluded.
2. Patients entering the HCP at any clinical phase of the disease (diagnosis, treatment of primary cancer, treatment of recurrence, treatment of M+ etc.). The HCP will collect information on the entire disease regardless of when it started to manage the patient. The HCP can choose, based on its resources, for how many patients will be able to collect the data.
3. New patients managed by the HCP from 2021 onwards + patients managed by the HCP, in active follow-up at the hospital

Exclusion Criteria:

1\. Patients whose medical records are unavailable for review

Where it's running

  • Fondazione del Piemonte per l'Oncologia - IRCCS
    Candiolo, Italy
    Recruiting
  • A.O.U. Careggi
    Florence, Italy
    Recruiting
  • P.O. 'Vito Fazzi'
    Lecce, Italy
    Recruiting
  • Fondazione IRCCS Istituto Nazionale Tumori
    Milan, Italy
    Recruiting
  • Fondazione CNAO
    Pavia, Italy
    Recruiting
  • Fondazione Policlinico Universitario 'Agostino Gemelli' IRCCS
    Roma, Italy
    Recruiting
Show 1 more location
  • Azienda Ospedaliera Universitaria Integrata di Verona
    Verona, Italy
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.